Viskase Holdings Inc

What they do

Viskase operates in the casing product segment of the food industry, producing cellulosic, fibrous and plastic casings for processed meat and poultry manufacturers. It operates eight significant manufacturing facilities across North America, Europe, South America and Asia and provides value-added support services to large global consumer products companies. Casing extrusion is capital-intensive with high fixed costs and continuous timed chemical processing, while finishing operations are labor intensive.

Revenue drivers

• Cellulosic casings — Viskase describes itself as one of the two largest worldwide producers of non-edible cellulosic casings for processed meats; revenue depends on processed meat demand, average selling prices and product mix.
• Fibrous casings — Viskase is one of the three largest manufacturers of non-edible fibrous casings, a second core product line subject to the same demand and pricing factors.
• Plastic casings — Plastic casings are a third extrusion product line listed alongside cellulosic and fibrous casings in the company's description of its operations.
• Value-added support services — Viskase provides support services relating to its casings for some of the world's largest global consumer products companies, though no separate revenue figure is disclosed.

Recent performance

Recent quarterly revenue was $86.5M for the quarter ended 2026-03-31 and $90.1M for 2026-06-30, down from $94.2M and $97.3M in the comparable 2025 quarters. The company reported 2025 net income of $-3.4M and diluted EPS of $-0.07, versus net income of $778,000 and diluted EPS of $-0.01 in 2024. Operating cash flow was $-3.0M in 2025 compared with $1.1M in 2024. At 2026-06-30 the company reported total assets of $424.5M, shareholder equity of $186.8M, cash and equivalents of $7.9M and long-term debt of $74.9M. The reported annual revenue figures in the XBRL data appear inconsistent with the quarterly revenue level and are not comparable.

Strategy

Management says its business strategy is to improve operational efficiencies, product quality and throughput by upgrading existing production facilities and adding resources in high-growth markets through new capital investments. The company says it has implemented production cost-savings initiatives and will continue to pursue similar opportunities to enhance profitability and competitive positioning. It is focused on reducing extrusion, shirring and printing waste through equipment upgrades and redefining product mix, and seeks entry into new value-added lines of business. Viskase believes current and planned cellulosic production capacity in the industry is in balance with global demand. The company completed its merger with Viskase Companies on March 26, 2026, became the surviving public holding company and changed its name from Enzon Pharmaceuticals, Inc. to Viskase Holdings, Inc., after a 1-for-100 reverse stock split.

Risks

• High fixed-cost, capital-intensive operations — Casing extrusion runs continuously with high fixed costs, so declines in volume or pricing pressure can disproportionately reduce gross profit.
• Dependence on processed meat demand — Net sales depend on consumer demand for meat products, population growth, overall processed meat consumption and the types of meat products consumers purchase.
• Capacity and industry supply balance — The industry's operating results have historically been sensitive to the global balance of capacity and demand, and Viskase operates at near capacity for certain products.
• Recent operating losses and negative cash flow — Viskase reported 2025 net income of $-3.4M and operating cash flow of $-3.0M, with quarterly revenue declining year over year in the first half of 2026.

Outlook

Management states that it believes current and planned cellulosic production capacity in the industry is in balance with global demand. The company intends to continue production cost-savings initiatives, upgrade existing facilities and add resources in high-growth markets through new capital investments. It also plans to pursue entry into new value-added lines of business. No specific financial guidance is provided in the excerpts.